Victor Oginga Oria

Victor Oginga Oria

Assistant Professor

ORCID: 0000-0001-7187-7916

Publication year:
All
1 - 3 out of 3Page size: 10
  1. 2023

  2. Lenvatinib or anti-VEGF in combination with anti-PD-1 differentially augments anti-tumor activity in melanoma

    Tran, T. T., Caulfield, J. I., Zhang, L., Schoenfeld, D. A., Djureinovic, D., Chiang, V. L., Oria, Victor Oginga, Weiss, S. A., Olino, K., Jilaveanu, L. B. & Kluger, H. M., 23 Feb 2023, (E-pub ahead of print) In: JCI insight.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy

    Piotrowski, Kris, Puig Blasco, Laia, Samsøe-Petersen, Jacob, Eefsen, R. L., Illemann, M., Oria, Victor Oginga, Campos, K. I. A., Lopresti, Alexia Mélanie, Albrechtsen, Reidar, Sørensen, Claus Storgaard, Sun, X. F., Kveiborg, Marie & Gnosa, S., 2023, In: Cancer Gene Therapy. 30, p. 1369-1381 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Tumor Angiocrine Signaling: Novel Targeting Opportunity in Cancer

    Oria, Victor Oginga & Erler, Janine, 2023, In: Cells. 12, 20, 14 p., 2510.

    Research output: Contribution to journal › Review › Research › peer-review

ID: 257450008